169 related articles for article (PubMed ID: 33516991)
1. Otomycosis in Africa: Epidemiology, diagnosis and treatment.
Sangaré I; Amona FM; Ouedraogo RW; Zida A; Ouedraogo MS
J Mycol Med; 2021 Jun; 31(2):101115. PubMed ID: 33516991
[TBL] [Abstract][Full Text] [Related]
2. Otomycosis in iran: a review.
Gharaghani M; Seifi Z; Zarei Mahmoudabadi A
Mycopathologia; 2015 Jun; 179(5-6):415-24. PubMed ID: 25633436
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of otomycosis in Ibadan: a review of laboratory reports.
Fayemiwo SA; Ogunleye VO; Adeosun AA; Bakare RA
Afr J Med Med Sci; 2010 Dec; 39 Suppl():219-22. PubMed ID: 22420052
[TBL] [Abstract][Full Text] [Related]
4. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia.
Tasić-Otašević S; Golubović M; Đenić S; Ignjatović A; Stalević M; Momčilović S; Bojanović M; Arsić-Arsenijević V
J Mycol Med; 2020 Sep; 30(3):101011. PubMed ID: 32693980
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents.
Aboutalebian S; Mahmoudi S; Mirhendi H; Okhovat A; Abtahi H; Chabavizadeh J
J Med Microbiol; 2019 Jun; 68(6):918-923. PubMed ID: 31063125
[TBL] [Abstract][Full Text] [Related]
6. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent.
Sabz G; Gharaghani M; Mirhendi H; Ahmadi B; Gatee MA; Sisakht MT; Hemati A; Mohammadi R; Taghavi J; Nouripour-Sisakht S
J Med Microbiol; 2019 Apr; 68(4):585-590. PubMed ID: 30801244
[TBL] [Abstract][Full Text] [Related]
7. Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases.
Naeimi B; Safari F; Ahmadikia K; Ahmadipour MJ; Sadeghzadeh F; Kondori N; Ahmadi B
Mycoses; 2024 Jan; 67(1):e13686. PubMed ID: 38214363
[TBL] [Abstract][Full Text] [Related]
8. Otomycosis in Shanghai: aetiology, clinical features and therapy.
Jia X; Liang Q; Chi F; Cao W
Mycoses; 2012 Sep; 55(5):404-9. PubMed ID: 21999222
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of otomycoses at the University Hospital of Yopougon (Abidjan-Ivory Coast)].
Adoubryn KD; N'Gattia VK; Kouadio-Yapo GC; Nigué L; Zika DK; Ouhon J
J Mycol Med; 2014 Jun; 24(2):e9-15. PubMed ID: 24139621
[TBL] [Abstract][Full Text] [Related]
10. The changing nature of paediatric otomycosis in the mid-west of Ireland.
Westby D; O'Connell N; Powell J; Fenton JE
J Laryngol Otol; 2020 Jul; 134(7):592-596. PubMed ID: 32713390
[TBL] [Abstract][Full Text] [Related]
11. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.
Javidnia J; Ghotbi Z; Ghojoghi A; Solhjoo K; Alshahni MM; Jeddi SA; Ahmadi B; Nouripour-Sisakht S; Ansari S; Shokoohi G
Mycopathologia; 2022 Jun; 187(2-3):225-233. PubMed ID: 35347533
[TBL] [Abstract][Full Text] [Related]
12. Treatment of otomycosis with clotrimazole: results accordingly with the fungus isolated.
Antunes J; Mendes N; Adónis C; Freire F
Acta Otolaryngol; 2022; 142(9-12):664-667. PubMed ID: 36128634
[TBL] [Abstract][Full Text] [Related]
13. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review.
Viswanatha B; Sumatha D; Vijayashree MS
Ear Nose Throat J; 2012 Mar; 91(3):114-21. PubMed ID: 22430336
[TBL] [Abstract][Full Text] [Related]
14. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.
Nemati S; Hassanzadeh R; Khajeh Jahromi S; Delkhosh Nasrollah Abadi A
Eur Arch Otorhinolaryngol; 2014 May; 271(5):953-7. PubMed ID: 23595615
[TBL] [Abstract][Full Text] [Related]
15. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
[TBL] [Abstract][Full Text] [Related]
16. Otomycosis caused by the cryptic and emerging species
Buonafina-Paz MD; Santos FA; Leite-Andrade MC; Alves AI; Bezerra JD; Leal MC; Robert E; Pape PL; Lima-Neto RG; Neves RP
Future Microbiol; 2022 Dec; 17():1437-1443. PubMed ID: 36382573
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of otomycosis in Khouzestan Province, south-west Iran.
Saki N; Rafiei A; Nikakhlagh S; Amirrajab N; Saki S
J Laryngol Otol; 2013 Jan; 127(1):25-7. PubMed ID: 23164073
[TBL] [Abstract][Full Text] [Related]
18. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.
Hagiwara S; Tamura T; Satoh K; Kamewada H; Nakano M; Shinden S; Yamaguchi H; Makimura K
Mycopathologia; 2019 Feb; 184(1):13-21. PubMed ID: 30291485
[TBL] [Abstract][Full Text] [Related]
19. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
20. The Role of Candida Albicans in Routine Clinically Suspected Otomycosis.
Amona FM; Wend-Lasida Ouedraogo R; Sangare I; Elola A
West Afr J Med; 2021 Aug; 38(8):743-748. PubMed ID: 34499919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
